BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Engitix

Engitix logo

Founded
2016
Geography
United Kingdom based
Funding
$6.371 M

Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered products for application in regenerative medicine and drug-target research. Engitix’ core expertise is treatment and research of liver disease using its proprietary technologies for human extra-cellular matrix (ECM) scaffolds and 3D spheroids for bioartificial liver devices. The scaffold technology is applicable to other organs and disease aetiologies including pancreatic and intestine scaffold products.


Posts Mentioning This Company

R&D Platform

-


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet